NCT01719692View on ClinicalTrials.gov

Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2015

Study Completion Date

February 29, 2016

Conditions
Immune Thrombocytopenic Purpura
Interventions
DRUG

Rituximab

Trial Locations (1)

300020

Hospital of Blood disease, Tianjin

All Listed Sponsors
collaborator

Langfang Traditional Chinese Medicine Hospital

UNKNOWN

collaborator

Henan Cancer Hospital

OTHER_GOV

collaborator

The Second Affiliated Hospital of Kunming Medical University

OTHER

lead

Institute of Hematology & Blood Diseases Hospital, China

OTHER

NCT01719692 - Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia | Biotech Hunter | Biotech Hunter